These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4510816)

  • 1. Treatment of acute myeloblastic leukaemia with RP 22050.
    Jacquillat C; Weil M; Gemon MF; Izrael V; Schaison G; Boiron M; Bernard J
    Br Med J; 1972 Nov; 4(5838):468-9. PubMed ID: 4510816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new agent active in the treatment of acute myeloblastic leukemia 22 050 RP.
    Jacquillat C; Weil M; Gemon MF; Izrael V; Boiron M; Bernard J
    Recent Results Cancer Res; 1973; 43():155-9. PubMed ID: 4531075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 4. Daunorubicin (NSC-83142) in advanced childhood leukemia.
    Jaffe N; Traggis DG; Das L
    Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of treatment of acute luekemia in adults according to our records].
    Kotlarek-Haus S; Witkowska M; Kuliszkiewicz M
    Acta Haematol Pol; 1975; 6(1):51-8. PubMed ID: 1054903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin in the treatment of acute leukaemia.
    Whitehouse JM; Crowther D; Bateman CJ; Beard ME; Malpas JS
    Br Med J; 1972 Feb; 1(5798):482-3. PubMed ID: 4500405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P].
    Bernard J; Jacquillat C; Boiron M; Weil M; Gémon MF; Izrael V; Schaison G; Delobel J
    Nouv Presse Med; 1972 Sep; 1(33):2149-52. PubMed ID: 4507740
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delivery of a normal child after chemotherapy of acute promyelocytic leukaemia during pregnancy (author's transl)].
    Gstöttner M; Frisch H; Dienstl F
    Blut; 1978 Mar; 36(3):171-4. PubMed ID: 273452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of acute myeliod leukaemia.
    Friend JH; Giles C; Richardson SG
    J Clin Pathol; 1974 Jan; 27(1):53-4. PubMed ID: 4522738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.
    Greene W; Huffman D; Wiernik PH; Schimpff S; Benjamin R; Bachur N
    Cancer; 1972 Dec; 30(6):1419-27. PubMed ID: 4264560
    [No Abstract]   [Full Text] [Related]  

  • 12. Endomyocardial fibrosis associated with daunorubicin therapy.
    Wilcox RG; James PD; Toghill PJ
    Br Heart J; 1976 Aug; 38(8):860-3. PubMed ID: 1067858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute myeloblastic leukemia. 79 cases treated by cytosine-rubidomycin combination].
    Brun B; Rochant H; Gluckman E; Reyes F; Dreyfus B
    Nouv Presse Med; 1974 Feb; 3(6):291-4. PubMed ID: 4522835
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 15. Daunorubicin and adriamycin in the treatment of leukemia.
    Klener P; Donner L; Kozená J
    Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Adriamycin in acute leukaemia.
    Smith IE; McElwain TJ
    Lancet; 1974 Jul; 2(7873):161. PubMed ID: 4135524
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
    Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study.
    Fassas A; Buffels R; Anagnostopoulos A; Gacos E; Vadikolia C; Haloudis P; Kaloyannidis P
    Br J Haematol; 2002 Feb; 116(2):308-15. PubMed ID: 11841431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):119-23. PubMed ID: 386480
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.